(CDRH Logo)The U.S. Food and Drug Administration
Center for Devices and Radiological Health (CDRH)
(HHS Logo)

Jump to page content...

CDRH Home|Search|A-Z Index|Feedback

510(k) Memorandum - #G95-1 Table 1

Initial Evaluation Tests for Consideration

Device Categories Biological Effect
Body Contact
(see 4.1)
Contact duration
(see 4.2)

A-limited
(24h)

B-prolonged
(24h to 30 days)

C-permanent
(>30days)
Surface
devices
Skin Axxx . . . ..
Bxxx . . . ..
Cxxx . . . ..
Mucosal
membrane
Axxx . . . ..
Bxxxoo .o.
Cxxxox xo.
Breached or
compromised
surfaces
Axxxo. ...
Bxxxoo .o.
Cxxxox xo.
External
communicating
devices
Blood path,
indirect
Axxxx. ..x
Bxxxxo ..x
Cxxoxx xox
Tissue/bone/
dentin
communicating+
Axxxo. ...
Bxxooo xx.
Cxxooo xx.
Circulating
blood
Axxxx. o^.x
Bxxxxo xox
Cxxxxx xox
Implant
devices
Tissue/
bone
Axxxo. ...
Bxxooo xx.
Cxxooo xx.
Blood Axxxx. .xx
Bxxxxo xxx
Cxxxxx xXx

X = ISO Evaluation Tests for Consideration
O = Additional Tests which may be applicable
Note + Tissue includes tissue fluids and subcutanous spaces
Note ^ For all devices used in extracorporial circuits

*See Table 2 for Supplementary Evaluation Tests

---
CDRH Home | Search | A-Z Index | Feedback | Accessibility | Disclaimer

 

(Updated April 12, 1996)